Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07832019 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Placenta-Cervical Interface Angle for Predicting Placenta Accreta Spectrum Severity

Study acronym: PCIA
StatusNot Yet Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Minor Study First Submitted
Placenta accreta spectrum (PAS) is associated with substantial maternal and neonatal morbidity, and accurate antenatal prediction of its severity remains challenging. Although several sonographic markers exist, most are subjective and operator-dependent, and few predict surgical complexity or adverse perinatal outcomes. This prospective observational cohort study evaluates the Placenta-Cervical Interface Angle (PCIA), a novel geometric transvaginal ultrasound marker, defined as the angle between the longitudinal axis of the cervical canal and the tangent line drawn to the lower placental edge. The study assesses the predictive performance of the PCIA for severe PAS and its association with intraoperative morbidity and adverse perinatal outcomes.
Trial Details
NCT Number NCT07832019
Lead Sponsor Necmettin Erbakan University
Conditions
(from sponsor)
Placenta Accreta Spectrum, Placenta Previa, Placenta Accreta
Related terms Placenta Accreta, Placenta Previa
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov